APIC joins coalition partners in supporting FDA Unique Device Identification proposal


With coalition partners, APIC sent comments the U.S. Food and Drug Administration (FDA) supporting proposed regulations that would require medical devices to carry a unique device identifier (UDI). UDIs will improve patient safety by providing increased information for adverse event reports, enabling FDA to more rapidly identify product complications and facilitate target recalls on faulty devices. Although APIC supports development of the UDI system, we expressed concern about the lengthy implementation schedule which allows up to seven years for the system to be fully carried out

<< return to Advocacy Updates